N-Nitroso Enzalutamide Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Enzalutamide is used to treat castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone), and metastatic castration-sensitive prostate cancer (prostate cancer that has spread to other parts of the body and responds to a hormone therapy or surgical.N-Nitroso Enzalutamide Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Enzalutamide Impurity 1 CAS NO:NA chemically represented as N-(4-Cyano-3-(trifluoromethyl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Enzalutamide Impurity 1.We supply N-Nitroso Enzalutamide Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142740 |
| CAS No | NA |
| Mol.F. | C15H9ClN3O5 |
| Mol.Wt. | 347.71g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142741 |
| CAS No | NA |
| Mol.F. | C30H20Cl2N6O9 |
| Mol.Wt. | 679.42 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142742 |
| CAS No | NA |
| Mol.F. | C21H23N3O5S |
| Mol.Wt. | 429.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142743 |
| CAS No | NA |
| Mol.F. | C20H21N3O5S |
| Mol.Wt. | 415.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142744 |
| CAS No | NA |
| Mol.F. | C18H16N2O5S |
| Mol.Wt. | 372.40 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142745 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142746 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142747 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142748 |
| CAS No | NA |
| Mol.F. | C17H17NO3S |
| Mol.Wt. | 344.39 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142749 |
| CAS No | NA |
| Mol.F. | C16H14N2O4S |
| Mol.Wt. | 330.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142750 |
| CAS No | NA |
| Mol.F. | C19H21N3O4S |
| Mol.Wt. | 387.45 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142751 |
| CAS No | NA |
| Mol.F. | C13H11N3O4S |
| Mol.Wt. | 305.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142752 |
| CAS No | NA |
| Mol.F. | C14H13N3O4S |
| Mol.Wt. | 319.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142753 |
| CAS No | NA |
| Mol.F. | C24H32N2O12S |
| Mol.Wt. | 601.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142754 |
| CAS No | NA |
| Mol.F. | C12H11N3O4S |
| Mol.Wt. | 293.30 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142755 |
| CAS No | NA |
| Mol.F. | C24H21N5O5S2 |
| Mol.Wt. | 523.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |